Inventor · disambiguated record
Christopher Larson
Also filed as: LARSON CHRISTOPHER · LARSON CHRISTOPHER J · LARSON CHRISTOPHER JAMES · LARSON CHRISTOPHER W
22 granted patents·12 pending applications·324 citations·filing 2001–2025
94Inventor score
Files withEPICENTRX INC15ITHERX PHARMACEUTICALS INC4UNITED TECHNOLOGIES CORP33M INNOVATIVE PROPERTIES CO2COMFORT KING OF SOUIX FALLS INC1
Top patents by PatentIndex Score
34 records- 0195US7863012B2Analysis of circulating tumor cells, fragments, and debrisVERIDEX LLC·Filed 2004·Granted Jan 4, 2011·134 cites·16 claims
- 0294US8329422B2Analysis of circulating tumor cells, fragments, and debrisRAO GALLA CHANDRA·Filed 2010·Granted Dec 11, 2012·81 cites·17 claims
- 0391US6617136B2Biological sample processing methods and compositions that include surfactants3M INNOVATIVE PROPERTIES CO·Filed 2001·Granted Sep 9, 2003·63 cites·45 claims
- 0490US9546560B2Compact double grounded mechanical carbon sealLARSON CHRISTOPHER J·Filed 2012·Granted Jan 17, 2017·14 cites·14 claims
- 0588US10906957B2Immunomodulatory fusion proteinsEPICENTRX INC·Filed 2017·Granted Feb 2, 2021·2 cites·8 claims
- 0686US11253608B2Recombinant adenoviruses carrying transgenesEPICENTRX INC·Filed 2018·Granted Feb 22, 2022·2 cites·24 claims
- 0784US12291726B2A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoterEPICENTRX INC·Filed 2024·Granted May 6, 2025·0 cites·19 claims
- 0884US2025074967A1Immunomodulatory fusion proteinsEPICENTRX INC·Filed 2024·Application pending·0 cites
- 0982US7919617B2Cytokine inhibitorsITHERX PHARMACEUTICALS INC·Filed 2009·Granted Apr 5, 2011·4 cites·3 claims
- 1082US7897599B2Cytokine inhibitorsITHERX PHARMACEUTICALS INC·Filed 2009·Granted Mar 1, 2011·4 cites·3 claims
- 1179US11834492B2Human IL-10 receptor alpha fusion proteinsEPICENTRX INC·Filed 2018·Granted Dec 5, 2023·1 cites·11 claims
- 1278US10167734B2Buffer airflow to bearing compartmentUNITED TECHNOLOGIES CORP·Filed 2013·Granted Jan 1, 2019·6 cites·17 claims
- 1377US8919134B2Intershaft seal with support linkageTATMAN NEIL L·Filed 2011·Granted Dec 30, 2014·7 cites·8 claims
- 1475US2024052016A1Human il-10 receptor alpha fusion proteinsEPICENTRX INC·Filed 2023·Application pending·0 cites
- 1573US12280123B2Recombinant adenoviruses carrying transgenesEPICENTRX INC·Filed 2022·Granted Apr 22, 2025·0 cites·17 claims
- 1671US12054530B2Immunomodulatory fusion proteinsEPICENTRX INC·Filed 2021·Granted Aug 6, 2024·0 cites·14 claims
- 1771US7749999B2Alpha-ketoamides and derivatives thereofITHERX PHARMACEUTICALS INC·Filed 2004·Granted Jul 6, 2010·5 cites·35 claims
- 1863US11999973B2Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoterEPICENTRX INC·Filed 2018·Granted Jun 4, 2024·0 cites·23 claims
- 1963US2025388930A1Tumor selective tata-box and caat-box mutantsEPICENTRX INC·Filed 2025·Application pending·0 cites
- 2056US10557774B2Mattress firmness testing process and systemLARSON CHRISTOPHER JAMES·Filed 2018·Granted Feb 11, 2020·1 cites·4 claims
- 2156US2006134162A1Methods for fabricating a drug delivery deviceLARSON CHRISTOPHER W·Filed 2004·Application pending·0 cites
- 2253US12295976B2Personalized cancer vaccinesEPICENTRX INC·Filed 2019·Granted May 13, 2025·0 cites·19 claims
- 2353US12036247B2Multiple transgene recombinant adenovirusEPICENTRX INC·Filed 2018·Granted Jul 16, 2024·0 cites·13 claims
- 2452US11459956B2Face seal arrangement with reduced balance ratioRAYTHEON TECH CORP·Filed 2020·Granted Oct 4, 2022·0 cites·20 claims
- 2551US2007212700A1Methods of using and analyzing biological sequence dataUNIV TEXAS·Filed 2006·Application pending·0 cites
- 2650US2010273797A1Alpha-ketoamides and derivatives thereofITHERX PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2749US2019352669A1Tumor selective tata-box and caat-box mutantsEPICENTRX INC·Filed 2018·Application pending·0 cites
- 2847US2020155625A1Anti-angiogenic adenovirusEPICENTRX INC·Filed 2018·Application pending·0 cites
- 2946US2003017567A1Biological sample processing methods and compositions that include surfactants3M INNOVATIVE PROPERTIES CO·Filed 2001·Application pending·0 cites
- 3045US9765692B2Systems and methods for load diversion around load sensitive partsUNITED TECHNOLOGIES CORP·Filed 2015·Granted Sep 19, 2017·0 cites·20 claims
- 3144US2019352616A1Multiple transgene recombinant adenovirusEPICENTRX INC·Filed 2018·Application pending·0 cites
- 3242US2013009364A1Shooting target with annunciation of engagement of targeted regions of the targetPINK MIST TECH LLC·Filed 2011·Application pending·0 cites
- 3337US2014119887A1Fluid-cooled seal arrangement for a gas turbine engineUNITED TECHNOLOGIES CORP·Filed 2012·Application pending·0 cites
- 3428USD995157SMattress support gelCOMFORT KING OF SOUIX FALLS INC·Filed 2021·Granted Aug 15, 2023·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Larson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →